In vitro anti-Helicobacter pylori activities of new rifamycin derivatives, KRM-1648 and KRM-1657.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/F1DF5EBA.svg?ark=w1%2F20260515%2FF1DF5EBA)](https://nobleid.org/work/w1/20260515/F1DF5EBA)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors